#1 Clinical Trials Search in Europe

Quetiapine

Quetiapine, also known by its brand name Seroquel, is an antipsychotic medication that has been studied in various clinical trials for its potential benefits in treating different mental health conditions. These trials have explored its use in schizophrenia, bipolar disorder, major depressive disorder, and other psychiatric conditions. The studies have examined different formulations, dosages, and patient populations to better understand quetiapine’s effectiveness, safety profile, and optimal use in clinical practice.

Table of Contents

What is Quetiapine?

Quetiapine, also known by its brand name Seroquel[1], is a medication classified as an atypical antipsychotic. It is widely used in the treatment of various mental health conditions. Quetiapine comes in two forms: immediate release (IR) and extended release (XR)[3]. The extended-release version is sometimes referred to as Seroquel XR[3].

Conditions Treated with Quetiapine

Quetiapine is used to treat several mental health conditions, including:

  • Schizophrenia: A severe mental disorder characterized by distortions in thinking, perception, emotions, language, sense of self, and behavior[2].
  • Bipolar Disorder: A condition that causes extreme mood swings that include emotional highs (mania or hypomania) and lows (depression)[6].
  • Major Depressive Disorder: A mood disorder causing a persistent feeling of sadness and loss of interest[5].
  • Generalized Anxiety Disorder: A condition characterized by persistent and excessive worry about various aspects of life[5].

Research is also being conducted to explore its potential use in treating other conditions such as cannabis dependence[7] and postpartum depression with psychotic symptoms[8].

How Quetiapine Works

Quetiapine affects multiple neurotransmitter receptors in the brain. It primarily works on:

  • Serotonin receptors: Helping to regulate mood and anxiety
  • Dopamine receptors: Influencing thought processes and behavior
  • Histamine receptors: Contributing to its sedative effects
  • Adrenergic receptors: Affecting various bodily functions[9]

By interacting with these receptors, quetiapine helps to balance the brain chemistry, potentially reducing symptoms of various mental health conditions.

Forms and Dosages

Quetiapine is available in tablet form and comes in various strengths, typically ranging from 25 mg to 300 mg[1][2]. The dosage prescribed depends on the condition being treated, the severity of symptoms, and individual patient factors. It’s important to note that dosages should only be adjusted under the guidance of a healthcare professional.

For example, in some studies:

  • Doses of 600 mg to 1200 mg per day were used for treatment-resistant schizophrenia[2].
  • A target dose of 150 mg per day was used for treating depression and anxiety[5].
  • Doses ranging from 25 mg to 300 mg twice daily were used in various studies[7][8].

Side Effects and Tolerability

Like all medications, quetiapine can cause side effects. Common side effects may include:

  • Drowsiness or sedation
  • Dizziness
  • Dry mouth
  • Weight gain
  • Changes in blood sugar levels

The tolerability of quetiapine can vary among individuals. Some studies have specifically looked at the tolerability of different formulations and dosing schedules[3]. It’s important to discuss any side effects with your healthcare provider.

Use in Special Populations

Quetiapine use in special populations, such as pregnant women and children, is an area of ongoing research:

  • Pregnancy: Studies are being conducted to understand how pregnancy affects the metabolism of quetiapine and to determine appropriate dosing during pregnancy and postpartum[6].
  • Children and Adolescents: Some research has explored the use of quetiapine in preschool children with bipolar disorder, but its use in pediatric populations requires careful consideration and monitoring[9].

Ongoing Research and Future Applications

Researchers continue to explore new potential uses for quetiapine and ways to optimize its use:

  • Its potential effectiveness in treating cannabis dependence is being studied[7].
  • Research is being conducted on its use in treating postpartum depression with psychotic symptoms[8].
  • Studies are investigating how bariatric surgery might affect the way the body processes quetiapine[4].

As with any medication, it’s crucial to use quetiapine only as prescribed by a healthcare professional. Regular check-ups and open communication with your doctor about any concerns or side effects are essential for safe and effective treatment.

Aspect Details
Conditions Studied Schizophrenia, Bipolar Disorder, Major Depressive Disorder, Generalized Anxiety Disorder, Cannabis Dependence, Postpartum Depression
Formulations Immediate-release (IR) and Extended-release (XR)
Dosage Ranges 25 mg to 1200 mg daily for adults; 2.5-5.0 mg/kg twice daily for children
Study Designs Randomized, Double-blind, Placebo-controlled, Crossover, Open-label
Efficacy Measures PANSS, Y-MRS, MADRS, HAM-A, CGI scales
Safety Assessments Extrapyramidal symptoms, Metabolic parameters, ECG, Sexual functioning
Special Populations Pregnant women, Postpartum women, Children, Bariatric surgery patients
Pharmacokinetic Studies Bioequivalence, Pregnancy effects, Bariatric surgery effects

FAQ

  • What conditions has quetiapine been studied for in clinical trials? Clinical trials have investigated quetiapine for various conditions, including schizophrenia, bipolar disorder, major depressive disorder, generalized anxiety disorder, cannabis dependence, and postpartum depression with psychotic symptoms. It has also been studied in healthy volunteers to assess its tolerability and pharmacokinetics.
  • What are the different formulations of quetiapine that have been studied? Clinical trials have examined both immediate-release (IR) and extended-release (XR) formulations of quetiapine. Some studies have compared the tolerability and effectiveness of these different formulations during initial dose escalation and in various treatment scenarios.
  • What dosage ranges of quetiapine have been investigated in clinical trials? The dosage ranges studied in clinical trials vary depending on the condition and patient population. For example, some trials have examined doses from 25 mg daily up to 1200 mg daily for adults with schizophrenia or bipolar disorder. In studies involving children or specific conditions, lower doses have been investigated, such as 2.5-5.0 mg/kg twice daily for preschool children with bipolar disorder.
  • How do clinical trials assess the effectiveness of quetiapine? Clinical trials use various standardized rating scales to measure the effectiveness of quetiapine. These may include the Positive and Negative Syndrome Scale (PANSS) for schizophrenia, the Young Mania Rating Scale (Y-MRS) for bipolar mania, the Montgomery-Åsberg Depression Rating Scale (MADRS) for depression, and the Hamilton Rating Scale for Anxiety (HAM-A) for anxiety symptoms. Researchers also often use the Clinical Global Impression (CGI) scales to assess overall improvement.
  • What are some of the side effects or safety concerns studied in quetiapine clinical trials? Clinical trials have monitored various side effects and safety concerns associated with quetiapine use. These include extrapyramidal symptoms, changes in metabolic parameters (such as weight gain and blood glucose levels), sedation, and changes in sexual functioning. Some studies have also examined the effects of quetiapine on heart rhythm through electrocardiogram (ECG) monitoring and its impact on pregnancy and postpartum periods.

Ongoing Clinical Trials on Quetiapine

  • Study on Melatonin and Quetiapine for Treating Insomnia in Adolescents with Psychiatric Disorders

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on the Effect of Citalopram, Sertraline, and Lithium for Patients with Bipolar Depression After First-Line Treatment Failure

    Recruiting

    1 1 1 1
    Investigated drugs:
    Austria Germany Greece Italy Spain

  • Study on Melatonin and Low-Dose Quetiapine for Patients with Psychiatric Disorders and Insomnia

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Testing a Pharmacogenetic-Guided Treatment Selection Strategy with Antidepressant Drug Combination for Patients with Depressive Disorder

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Spain

  • Study on Enhanced Treatment for Schizophrenia, Depression, and Bipolar Disorder Using Esketamine, Bupropion, and Quetiapine for Patients with Initial Treatment Failure

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Germany Italy Spain

  • Study on Continuing or Reducing Antipsychotic Medication (Haloperidol, Clozapine, Tiapride) for Patients After First Episode of Psychosis

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

Glossary

  • Quetiapine: An atypical antipsychotic medication used to treat various mental health conditions, also known by the brand name Seroquel.
  • Bioequivalence: The property of two drug products having the same active ingredient, dosage form, strength, and route of administration to be pharmaceutically equivalent and to have similar biological effects when administered to patients.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Extended-release (XR): A formulation of a medication designed to release the active ingredient slowly over time, allowing for less frequent dosing.
  • Immediate-release (IR): A formulation of a medication designed to release the active ingredient quickly after administration.
  • Double-blind: A study design where neither the participants nor the researchers know who is receiving the active treatment or placebo.
  • Placebo: An inactive substance or treatment used in clinical trials as a control to compare against the active medication being studied.
  • Randomized: A method of assigning participants to different treatment groups in a study by chance, to reduce bias.
  • Crossover study: A type of clinical trial where participants receive different treatments in a specific order, allowing each participant to serve as their own control.
  • Area under the curve (AUC): A measure used in pharmacokinetics to represent the total exposure to a drug over time.
  • Visual Analog Scale (VAS): A measurement tool used to assess subjective characteristics or attitudes that cannot be directly measured.
  • Extrapyramidal symptoms: Movement disorders that can occur as side effects of antipsychotic medications, including muscle stiffness, tremors, and restlessness.
  • Cognitive Behavioral Therapy (CBT): A type of psychotherapy that focuses on changing negative thought patterns and behaviors to improve mental health.

References

  1. https://clinicaltrials.gov/study/NCT01566487
  2. https://clinicaltrials.gov/study/NCT00297947
  3. https://clinicaltrials.gov/study/NCT00702676
  4. https://clinicaltrials.gov/study/NCT03449472
  5. https://clinicaltrials.gov/study/NCT01971203
  6. https://clinicaltrials.gov/study/NCT02978534
  7. https://clinicaltrials.gov/study/NCT00954681
  8. https://clinicaltrials.gov/study/NCT00681668
  9. https://clinicaltrials.gov/study/NCT00181883